TGFB1 and coronary artery disorder: Individuals with increased risk for coronary artery disease presented reduced interleukin-1 (IL-1), IL-6, TNF-α, and C-reactive levels, together with improved IL-10 and transforming growth factor beta-1 systemic levels after an ET program [30].